Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis

E. S. Dellon, L. L. Higgins, R. Beitia, S. Rusin, J. T. Woosley, R. Veerappan, S. R. Selitsky, J. S. Parker, R. M. Genta, R. H. Lash, R. Aranda, R. J. Peach, M. Grimm

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Background Periostin is highly expressed in eosinophilic oesophagitis (EoE), but has not been extensively studied as a non-invasive biomarker. Aim To assess whether serum periostin distinguished EoE from controls at baseline, had utility for monitoring treatment response, or was associated with IL-13 levels. Methods This was a sub-analysis of a prospective cohort study of adults undergoing out-patient upper endoscopy. Incident cases of EoE were diagnosed per consensus guidelines. Controls were subjects with either GERD or dysphagia without EoE. EoE patients were treated with swallowed/topical steroids and had repeat endoscopy/biopsy. Serum periostin levels for cases and controls were compared at baseline, and pre/post-treatment levels were compared for cases. Serum IL-13 and tissue expression of periostin were also assessed. Results A total of 61 incident EoE cases and 87 controls were analysed. Despite a marked increase in tissue periostin expression in cases, the median baseline serum periostin level was only slightly higher in cases than controls (22.1 ng/mL vs. 20.7; P = 0.04); there was no change in post-treatment levels. There was also no difference in serum periostin for cases by histologic response or atopic status. There was a strong trend towards higher serum IL-13 levels in cases in the highest periostin quartile (57.1 pg/mL vs. 2.6; P = 0.07). Conclusions Serum periostin levels were similar in cases and controls, and there were no changes post-treatment. Given elevated IL-13 levels in the EoE patients with the highest periostin levels, future studies could explore periostin as a biomarker in EoE, perhaps in the setting of anti-IL-13 therapy.

Original languageEnglish (US)
Pages (from-to)189-197
Number of pages9
JournalAlimentary Pharmacology and Therapeutics
Volume44
Issue number2
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis'. Together they form a unique fingerprint.

Cite this